Patents by Inventor Andrew James Carpenter

Andrew James Carpenter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide YY analogs
    Patent number: 9441023
    Abstract: The present invention relates to novel analogs of PYY that have an improved therapeutic profile when compared to native human PYY. These novel PYY analogs are useful in the treatment of obesity, diabetes, and other disorders.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: September 13, 2016
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Steven Thomas Dock, Andrew James Carpenter, Robert Neil Hunter, III, Yulin Wu, Ved P. Srivastava
  • THERAPEUTIC PEPTIDES
    Publication number: 20160108098
    Abstract: The present invention relates to novel analogs of PYY that have an improved therapeutic profile when compared to native human PYY. These novel PYY analogs are useful in the treatment of obesity, diabetes, and other disorders.
    Type: Application
    Filed: April 30, 2014
    Publication date: April 21, 2016
    Inventors: Steven Thomas DOCK, Yulin WU, Ved P Srivastava, Robert Neil HUNTER, III, Andrew James CARPENTER
  • THERAPEUTIC PEPTIDES
    Publication number: 20140329742
    Abstract: The present invention relates to novel analogs of PYY that have an improved therapeutic profile when compared to native human PYY. These novel PYY analogs are useful in the treatment of obesity, diabetes, and other disorders.
    Type: Application
    Filed: April 30, 2014
    Publication date: November 6, 2014
    Applicant: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Steven Thomas Dock, Andrew James Carpenter, Robert Neil Hunter, III, Yulin Wu, Ved P. Srivastava
  • Treatment Of Blood Lipid Abnormalities And Other Conditions
    Publication number: 20140249156
    Abstract: There is provided a method of treatment of a patient suffering from blood lipid abnormality comprises the administration of a GPR119 agonist.
    Type: Application
    Filed: October 31, 2012
    Publication date: September 4, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Kathleen Brown, Andrew James Carpenter, Derek J.R. Nunez, Andrew Young
  • N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR
    Publication number: 20100286152
    Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof,
    Type: Application
    Filed: June 5, 2008
    Publication date: November 11, 2010
    Applicant: Glaxo Group Limited
    Inventors: Giovanni Bernasconi, Steven Mark Bromidge, Andrew James Carpenter, Lucilla D'Adamo, Romano Di Fabio, Sebastien Guery, Francesca Pavone, Alfonso Pozzan, Marilisa Rinaldi, Fabio Maria Sabbatini, Yves St-Denis